P3.01-69 Stereotactic Ablative Radiotherapy Improves Progression-Free Survival and Local Control in Oligometastatic Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1629 ◽

2018 ◽

Vol 13 (10) ◽

pp. S893-S894

Author(s):

F. Maldonado

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Local Control ◽

Progression Free Survival ◽

Stereotactic Ablative Radiotherapy ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

Baseline Population Characteristics And The Association Between Progression-Free Survival And Overall Survival In Advanced Non-Small Cell Lung Cancer Patients

Value in Health ◽

10.1016/j.jval.2017.08.134 ◽

2017 ◽

Vol 20 (9) ◽

pp. A420-A421

Author(s):

M Kulakova ◽

M Hashim ◽

B Pfeiffer ◽

M Postma ◽

B Heeg

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Progression Free Survival ◽

Population Characteristics ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

Relationship between Overall Survival and Response or Progression-Free Survival in Advanced Non–Small Cell Lung Cancer Patients Treated with Anti–PD-1/PD-L1 Antibodies

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.07.017 ◽

2016 ◽

Vol 11 (11) ◽

pp. 1927-1939 ◽

Author(s):

Takehito Shukuya ◽

Keita Mori ◽

Joseph M. Amann ◽

Erin M. Bertino ◽

Gregory A. Otterson ◽

...

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Progression Free Survival ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

P3.01-05 Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1565 ◽

2018 ◽

Vol 13 (10) ◽

pp. S868-S869

Author(s):

P. Bhatt ◽

P. Bonomi ◽

S. Basu ◽

M. Batus

Keyword(s):

Lung Cancer ◽

Maintenance Therapy ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Stage Iv ◽

Progression Free Survival ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

Evaluation of Association of Progression-Free Survival (Pfs) with Health-Related Quality of Life (Hrqol) in Lung Cancer Patients (Pts)

Annals of Oncology ◽

10.1093/annonc/mdu349.47 ◽

2014 ◽

Vol 25 ◽

pp. iv446

Author(s):

Y. Wu ◽

M. Palmer ◽

S. Ellis ◽

I. Griebsch ◽

J. Lungershausen

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Cancer Patients ◽

Progression Free Survival ◽

Health Related Quality ◽

Free Survival ◽

Lung Cancer Patients ◽

Related Quality ◽

Download Full-text

Continuation of gefitinib plus chemotherapy prolongs progression-free survival in advanced non-small cell lung cancer patients who get acquired resistance to gefitinib without T790M mutations

Journal of Thoracic Disease ◽

10.21037/jtd.2017.07.107 ◽

2017 ◽

Vol 9 (9) ◽

pp. 2923-2934 ◽

Author(s):

Ting Ding ◽

Fei Zhou ◽

Xiaoxia Chen ◽

Shijia Zhang ◽

Yinan Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Acquired Resistance ◽

Progression Free Survival ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

Abstract 856: Number of ALK-amplified circulating tumor cells predicts progression-free survival in ALK-rearranged non-small cell lung cancer patients treated by crizotinib

10.1158/1538-7445.am2016-856 ◽

2016 ◽

Author(s):

Emma Pailler ◽

Marianne Oulhen ◽

Kirsty Ross ◽

Fanny Billiot ◽

Nathalie Auger ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Progression Free Survival ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

A Case Series of Lengthy Progression-Free Survival With Pemetrexed-Containing Therapy in Metastatic Non–Small-Cell Lung Cancer Patients Harboring ROS1 Gene Rearrangements

Clinical Lung Cancer ◽

10.1016/j.cllc.2013.04.008 ◽

2013 ◽

Vol 14 (5) ◽

pp. 592-595 ◽

Author(s):

Jonathan W. Riess ◽

Sukhmani K. Padda ◽

Charles D. Bangs ◽

Millie Das ◽

Joel W. Neal ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Case Series ◽

Progression Free Survival ◽

Gene Rearrangements ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

Predictors of Response, Progression Free Survival, and Overall Survival in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.03.017 ◽

2021 ◽

Author(s):

Regan M. Memmott ◽

Adam R. Wolfe ◽

David P. Carbone ◽

Terence M. Williams

Keyword(s):

Lung Cancer ◽

Overall Survival ◽

Cancer Patients ◽

Immune Checkpoint ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Progression Free Survival ◽

Free Survival ◽

Lung Cancer Patients ◽

Predictors Of Response

Download Full-text

PCN33 Real-World Progression-Free Survival by Timing of Molecular Profiling Testing Among Metastatic Non-Small Cell Lung Cancer Patients in a Community Setting

Value in Health ◽

10.1016/j.jval.2021.04.125 ◽

2021 ◽

Vol 24 ◽

pp. S24

Author(s):

S. Liu ◽

R. DeClue ◽

A. Nisbett ◽

S. Gautam ◽

M.D. Fisher ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Community Setting ◽

Progression Free Survival ◽

Molecular Profiling ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text

Mature progression-free survival (PFS) milestones in real world stage IV, non-squamous, non-small cell lung cancer patients (nsqNSCLC) treated with first line pemetrexed(Pem)/platinum(Plat) +/- bevacizumab(Bev) followed by pem +/-bev maintenance.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e21063 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e21063-e21063

Author(s):

Parva Kiran Bhatt ◽

Philip D. Bonomi ◽

Sanjib Basu ◽

Mary J. Fidler ◽

Marta Batus

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Stage Iv ◽

Progression Free Survival ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients

Download Full-text